Research Focus

Former Employee. Molecular Pharmacology Program; Research Fellow

Recent additions – View all

1. ET743, a novel transcription-targeted chemotherapeutic that inhibits activation of the MDR1 promoter by multiple inducers

   Meeting Abstract

   Gorfajn, B. D.; Jin, S.; Hu, Z.; Scotto, K. W.
   Proceedings of the American Association for Cancer Research Annual Meeting (2000)

   Fulltext@MSK | Save
2. Ecteinascidin 743, a novel chemotherapeutic agent that targets transcriptional activation of a subset of genes, including MDR1

   Meeting Abstract

   Scotto, K. W.; Jin, S. K.; Gorfajn, B.; Hu, Z.; Shtil, A.
   Clinical Cancer Research (2000)

   Fulltext@MSK | Save
3. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation

   Journal Article

   Jin, S.; Gorfajn, B.; Faircloth, G.; Scotto, K. W.
   Proceedings of the National Academy of Sciences of the United States of America (2000)

   Fulltext@MSK | Save